Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): Epidemiology, microbiology and histopathology

Journal of Medical Microbiology

Volumn 53, Issue 9, 2004, Pages 935-940

  Hoang, Linda M N ^a   Maguire, John A ^a   Doyle, Patrick ^a   Fyfe, Murray ^b   Roscoe, Diane L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BACTERIUM CULTURE; BRAIN BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS LAURENTII; CRYPTOCOCCUS NEOFORMANS; ENCEPHALITIS; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; INFECTION RATE; LUNG BIOPSY; LUNG FIBROSIS; LUNG GRANULOMA; LUNG INFECTION; MALE; MEDICAL RECORD; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; BRITISH COLUMBIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 4544251213     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05427-0     Document Type: Review

References (22)

1. Boei, W. (2002). Tropical fungus a mystery in B.C. The Vancouver Sun June 7, A4.
2. Bonacini, M., Nussbaum, J. & Ahluwalia, C. (1990). Gastrointestinal, hepatic, and pancreatic involvement with Cryptococcus neoformans in AIDS. J Clin Gastroenterol 12, 295-297.
3. Buchanan, K. L. & Murphy, J. W. (1998). What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4, 71-82.
4. Chen, S., Sorrell, T. & Nimmo, G. (2000). Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 31, 499-508.
5. Collins, H. L. & Bancroft, G. J. (1991). Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun 59, 3883-3888.
6. Daly, J. S., Porter, K. A., Chong, F. K. & Robillard, R. J. (1990). Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Am J Gastroenterol 85, 1421-1424.
7. Dong, Z. M. & Murphy, J. W. (1995). Intravascular cryptococcal culture filtrate (CneF) and its major component glucuronoxylomannan (GXM) are potent inhibitors of leukocyte accumulation. Infect Immun 63, 770-778.
8. Fyfe, M., Black, W., Romney, M. & 10 other authors (2002). Unprecedented outbreak of Cryptococcus neoformans var. gattii infections in British Columbia, Canada. In Abstracts of the 5th International Conference on Cryptococcus and Cryptococcosis, March 3-7, 2002. Adelaide.
9. Jang, B. (2002). Vancouver Island scares off tourists. The Globe and Mail July 10, A1.
10. Kerkering, T. M., Duma, R. J. & Shadomy, S. (1981). The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 94, 611-616.
11. Kozel, T. R. & Mastroianni, R. P. (1976). Inhibition of phagocytosis by cryptococcal polysaccharide; dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun 14, 62-67.
12. Kwon-Chung, K. J. (1992). Cryptococcosis. In Medical Mycology, pp. 397-446. Edited by K. J. Kwon-Chung & J. E. Bennett. Philadelphia; Lea & Febiger.
13. Kwon-Chung, K. J., Polacheck, I. & Bennet, J. (1982). Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15, 535-537.
14. Lacomis, J. M., Costello, P., Vilchez, R. & Kusne, S. (2001). The radiology of pulmonary cryptococcosis in a tertiary medical center. J Thorac Imaging 16, 139-148.
15. McNeill, J. I. & Kan, V. L. (1995). Decline in the incidence of cryptococcosis among HIV-related patients. J Acquir Immune Defic Syndr Hum Retrovirol 206, 207.
16. Mirza, S. A., Phelan, M., Rimland, D. & 8 other authors (2003). The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000, Clin Infect Dis 36, 789-794.
17. Murphy, J. W. & Moorhead, J. W. (1982). Regulation of cell-mediated immunity in cryptococcosis. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol 128, 276-283.
18. van Eiden, L. J., Walenkamp, A. M. & Lipovsky, M. M. (2000). Declining number of patients with cryptococcosis in The Netherlands in the area of highly active antiretroviral therapy. AIDS 14, 2787-2788.
19. Vecchiarelli, A., Retini, C., Pietrella, D., Monari, C., Tascini, T., Beccari, T. & Kozel, T. R. (1995). Downregulation by cryptococcal polysaccharide of tumour necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 63, 2919-2923.
20. Washington, K., Gottfried, M. R. & Wilson, M. L. (1991). Gastrointestinal cryptococcosis. Mod Pathol 4, 707-711.
21. Wong, B., Perfect, J. R., Beggs, S. & Wright, K. A. (1990). Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun 58, 1664-1670.
22. Zinck, S. E., Leung, A. N., Frost, M., Berry, G. J. & Muller, N. L. (2002). Pulmonary cryptococcosis: CT and pathologic findings. J Comput Assisted Tomogr 26, 330-334.